Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.

A recent international clinical trial published in the journal of The Lancet Rheumatology found that sarilumab 200 mg every 2 ...

(RTTNews) - Novartis (NVS,NOVN.SW) announced that its interleukin-17A inhibitor Cosentyx (secukinumab) met the primary and all secondary endpoints in the Phase III REPLENISH trial. The study evaluated ...

Arthritis is a general term encompassing many of these different conditions, with common ones being osteoarthritis, back pain, rheumatoid arthritis, fibromyalgia, osteoporosis, gout, polymyalgia ...

Polymyalgia rheumatica is the second most common inflammatory rheumatic disease in adults aged 50 years and older, typically characterized by acute pain and stiffness in the shoulders, neck, and hips.

If your ability to work is limited due to your symptoms, you could qualify for 'new style' Employment and Support Allowance (ESA). The most recent DWP data also reveals that there are now over 3.8 ...

Q3 2025 Earnings Call Transcript October 28, 2025 Novartis AG misses on earnings expectations. Reported EPS is $2.25 EPS, ...

Good morning and good afternoon, everyone, and welcome to our Q3 2025 earnings call. The information presented today contains forward-looking statements that involve known and unknown risks, ...

The Department for Work and Pensions (DWP) has unveiled new stats, showing that nearly 1.2 million adults across Great Britain are now receiving Personal Independence Payment (PIP) support for over 85 ...

It’s no secret that vitamin D is an essential nutrient, best known for its role in bone health and immune function. It’s ...

Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +7% (cc1, +8% USD) and core operating income1 grew +7% (cc, +6% USD) Sales growth was driven by continued strong execution on priority ...

Existential authenticity is the act of being true to existence in and of itself, rather than being true to yourself in a ...